| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |